David P. Rosenbaum - 04 Nov 2024 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role: Chief Development Officer
Signature: /s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Issuer symbol: ARDX
Transactions as of: 04 Nov 2024
Net transactions value: -$161,673
Form type: 4
Filing time: 06 Nov 2024, 17:59:30 UTC
Previous filing: 01 Oct 2024
Next filing: 08 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARDX	Common Stock	Options Exercise	$63,039	+27,172	+18%	$2.32	180,788	04 Nov 2024	By Wife	F1
transaction	ARDX	Common Stock	Sale	$161,673	-27,172	-15%	$5.95	153,616	04 Nov 2024	By Wife	F1
holding	ARDX	Common Stock						301,946	04 Nov 2024	Direct
holding	ARDX	Common Stock						77,592	04 Nov 2024	Family Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARDX	Stock Option (Right to Buy)	Options Exercise	$63,039	-27,172	-50%	$2.32	27,171	04 Nov 2024	Common Stock	27,172	$2.32	By Wife	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are directly held by the Reporting Person's wife.
F2	The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
F3	The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.